Since the outbreak of COVID-19 in December 2019, which was caused SARS-CoV-2, COVID-19-associated ALI/ARDS has been widely discussed, and the role of NLRP3 inflammasome in its progressing has received great attention. The gene discussed is NLRP3; the disease is COVID-19.